Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06714721

Magnetic Stimulation of Diaphragm in Chronic Obstructive Pulmonary Disease

Led by Ankara University · Updated on 2024-12-04

66

Participants Needed

1

Research Sites

119 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation and respiratory symptoms due to airway and/or alveolar deterioration caused by severe exposure to harmful particles or gases and host factors. Exercise intolerance and decreased functional capacity develop as a result of the disorders that occur in COPD. The aim of this study is to evaluate the effectiveness of repetitive peripheral magnetic stimulation (rPMS), an easy and inexpensive method to increase diaphragm strength as an adjunct to the pulmonary rehabilitation (PR) program applied in COPD, and to investigate the effect of this method on exercise capacity, diaphragm muscle thickness and symptoms.

CONDITIONS

Official Title

Magnetic Stimulation of Diaphragm in Chronic Obstructive Pulmonary Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with COPD at least 6 months ago
  • At least 18 years of age
  • Able to understand questions and complete questionnaires
  • Agree to participate in the study
Not Eligible

You will not qualify if you...

  • Chest wall deformity
  • Having a pacemaker or defibrillator
  • Pregnancy
  • Acute respiratory infection or pneumonia
  • Suspected hemidiaphragmatic paresis
  • History of inflammatory rheumatologic or neuromuscular diseases affecting diaphragm
  • Suspected paraneoplastic or myopathic syndromes or use of muscle-altering medications including oral corticosteroids
  • Recent thoracic or abdominal surgery
  • COPD exacerbation within last 4 weeks
  • COPD with bronchial asthma, interstitial lung disease, lung cancer, or metabolic diseases (diabetes, uremia, liver failure)
  • Body mass index over 40
  • Contraindications for exercise such as uncontrolled arrhythmias, very high blood pressure, severe aortic stenosis, recent embolism, decompensated heart failure, recent cardiac ischemic event
  • Systemic or musculoskeletal diseases preventing exercise

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ankara University Faculty of Medicine Department of Physical Medicine and Rehabilitation

Ankara, Turkey (Türkiye), 06620

Actively Recruiting

Loading map...

Research Team

Y

Yeşim Aytur, Professor, MD

CONTACT

M

Meltem Kaya, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here